CD
Christopher C Dvorak
University of California, San Francisco
Research areas: Medicine · Hematology · Hematopoietic Stem Cell Transplantation · Immunodeficiency and Autoimmune Disorders · Transplantation: Methods and Outcomes
0000-0002-6146-3952
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (467)
- High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation Save
- Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report Save
- Pediatric Nonmalignant Hematopoietic Cell Transplantation in the Era of Precision Conditioning and Gene Therapy. Save
- Corrigendum to ‘2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and… Save
- On Hierarchical Composite Endpoints in Pediatric Cancer Supportive Care: Illustrative Examples From Two Multi‐Center Phase‐III Randomized Clinical Trials Save
- Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation Save
- IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC) Save
- Rabbit Antithymocyte Globulin Refractoriness or Induced Lymphocytosis in Alpha-Beta T Cell-Depleted Hematopoietic Cell Transplantation Recipients Save
- In utero hematopoietic cell transplantation in fetuses with α-thalassemia major: a phase 1 clinical trial Save
- Eculizumab for Pediatric Hematopoietic Cell Transplant–Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment Save
- Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study Save
- Ravulizumab plus best supportive care in pediatric patients with hematopoietic stem cell transplantation-associated thrombotic microangiopathy: 52-week results from a phase 3 trial Save
- Yes, we can omit TBI for ALL! Save
- Upper and Lower Respiratory Tract Compartmentalization in Pediatric Stem Cell Transplantation Save
- Acute adverse events associated with commercially available chimeric antigen receptor (CAR)-T cell infusions in the adult and pediatric population: a 5-year retrospective analysis Save
- Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant Save
- 2025 Inborn errors of immunity practice parameter Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Imm… Save
- Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Save
- Half-Matched Comes at What Cost?: A Cohort Cost Analysis of the PTCTC ONC1401 Trial Utilizing the Pediatric Health Systems Information (PHIS) Database Save
- Outcomes in paediatric patients with HSCT-TMA treated with ravulizumab Save